Secondary Prevention and Application-based Lifestyle Support for Patients With Intermittent Claudication

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

February 22, 2022

Study Completion Date

February 28, 2022

Conditions
Intermittent ClaudicationVascular Diseases
Interventions
BEHAVIORAL

Application-based support system

All participants (experimental and control group) will be invited to a separate appointment at the vascular open clinic at baseline and after three months and measured regarding weight, blood pressure, Ankle Brachial Pressure Index, six minutes walking test and pain. To calculate the estimate 10-year risk of manifesting clinical cardiovascular disease, the Framingham Risk Score will be used. Further, a questionnaire will be answered at baseline and after three months containing the instruments, VascuQoL-6, Health Education Impact Questionnaire and Medication Adherence Report Scale-5.

Trial Locations (1)

20506

Christine Kumlien, Malmo

All Listed Sponsors
collaborator

Skane University Hospital

OTHER

lead

Malmö University

OTHER

NCT04390282 - Secondary Prevention and Application-based Lifestyle Support for Patients With Intermittent Claudication | Biotech Hunter | Biotech Hunter